John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$254M |
| 2 |
Bank of America
BAC
|
+$228M |
| 3 |
KLA
KLAC
|
+$205M |
| 4 |
TSMC
TSM
|
+$191M |
| 5 |
CVS Health
CVS
|
+$182M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.06B |
| 2 |
Meta Platforms (Facebook)
META
|
+$254M |
| 3 |
Goldman Sachs
GS
|
+$237M |
| 4 |
Amazon
AMZN
|
+$229M |
| 5 |
PayPal
PYPL
|
+$212M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.63% |
| 2 | Healthcare | 13.66% |
| 3 | Financials | 12.92% |
| 4 | Industrials | 10.81% |
| 5 | Consumer Discretionary | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
Bausch + Lomb
BLCO
$6.19B
| $394K | ﹤0.01% |
+20,402
| New | +$337K |
|
2527
MarineMax
HZO
$1.15B
| $392K | ﹤0.01% |
11,123
-6,214
| -36% | -$203K |
|
2528
Sabra Healthcare REIT
SBRA
$5.23B
| $390K | ﹤0.01% |
20,949
+619
| +3% | +$10.4K |
|
|
ALAR
2529
Alarum Technologies
ALAR
$12.5M
| $384K | ﹤0.01% |
+36,104
| New | +$777K |
|
2530
Cullinan Oncology
CGEM
$1.4B
| $384K | ﹤0.01% |
22,944
-34,417
| -60% | -$610K |
|
2531
PubMatic
PUBM
$745M
| $384K | ﹤0.01% |
25,800
-11,198
| -30% | -$194K |
|
2532
C&F Financial
CFFI
$283M
| $384K | ﹤0.01% |
+6,573
| New | +$356K |
|
2533
TETRA Technologies
TTI
$1B
| $383K | ﹤0.01% |
123,702
-116,413
| -48% | -$376K |
|
|
CCRN
2534
DELISTED
Cross Country Healthcare
CCRN
| $383K | ﹤0.01% |
+28,518
| New | +$420K |
|
|
SLSR
2535
Solaris Resources
SLSR
$1.44B
| $383K | ﹤0.01% |
+147,014
| New | +$358K |
|
2536
Werewolf Therapeutics
HOWL
$42.9M
| $383K | ﹤0.01% |
180,608
-38,758
| -18% | -$88.2K |
|
2537
Telecom Argentina
TEO
$5.84B
| $380K | ﹤0.01% |
50,343
+3,837
| +8% | +$27.5K |
|
2538
West Bancorporation
WTBA
$485M
| $380K | ﹤0.01% |
+19,967
| New | +$383K |
|
2539
Upland Software
UPLD
$14M
| $379K | ﹤0.01% |
15,234
+3,190
| +26% | +$73.5K |
|
2540
Hawkins
HWKN
$2.46B
| $379K | ﹤0.01% |
+2,974
| New | +$337K |
|
2541
Corvus Pharmaceuticals
CRVS
$1.19B
| $378K | ﹤0.01% |
71,552
+23,766
| +50% | +$85.3K |
|
|
SEVN
2542
Seven Hills Realty Trust
SEVN
$176M
| $378K | ﹤0.01% |
+27,419
| New | +$369K |
|
2543
Leslie's
LESL
$5.44M
| $377K | ﹤0.01% |
+5,970
| New | +$368K |
|
|
ABLLW
2544
DELISTED
Abacus Life Warrant
ABLLW
| $376K | ﹤0.01% |
+220,931
| New | +$261K |
|
2545
Select Water Solutions
WTTR
$2.48B
| $376K | ﹤0.01% |
33,745
-15,751
| -32% | -$173K |
|
|
GBIO
2546
DELISTED
Generation Bio
GBIO
| $370K | ﹤0.01% |
14,990
-7,952
| -35% | -$210K |
|
2547
Axogen
AXGN
$2.65B
| $370K | ﹤0.01% |
+26,393
| New | +$292K |
|
2548
Invesco Oil & Gas Services ETF
PXJ
$65.8M
| $369K | ﹤0.01% |
+12,780
| New | +$391K |
|
2549
Invesco International Dividend Achievers ETF
PID
$918M
| $368K | ﹤0.01% |
+18,600
| New | +$355K |
|
2550
inTEST
INTT
$145M
| $367K | ﹤0.01% |
50,304
-12,244
| -20% | -$102K |
|
Similar funds
John Overdeck's Q3 2024 Portfolio in Review
As of Q3 2024, John Overdeck held 3,433 positions worth $45.6B, up 3.9% from $43.9B the previous quarter. Its ten largest holdings account for 6.6% of the portfolio.
John Overdeck withdrew a net $1.83B in Q3 2024, closing 348 positions and reducing 1,306 holdings. Its most notable exit was Intel, an estimated $161M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
Against the trend, John Overdeck opened a new position in Bank of America worth $226M.
- John Overdeck's largest Q3 2024 buy was Bank of America: 5,683,991 shares worth $226M.
- John Overdeck added most to Alphabet (Google) Class A in Q3 2024, an estimated $254M increase.
- John Overdeck's biggest Q3 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.06B.
- John Overdeck fully exited Intel in Q3 2024, selling an estimated $161M.
- John Overdeck's ten largest holdings make up 6.6% of its $45.6B portfolio in Q3 2024.
- John Overdeck opened 444 new positions and closed 348 in Q3 2024.
- John Overdeck's portfolio value rose 3.9% quarter-over-quarter to $45.6B.
Based on Two Sigma Investments's 13F filing for Q3 2024, filed 14 Nov 2024.